Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Alzheimer's Disease

Free Subscription Articles published in BMC Neurol Retrieve available abstracts of 57 articles: HTML format

Single Articles

January 2026
1. LOBO JD, Serrano VB, Campbell LM, Bell T, et al
   Cerebrospinal fluid markers of alzheimer's pathology relate to aMCI among people with HIV.
   BMC Neurol. 2026 Jan 17. doi: 10.1186/s12883-025-04585.
   PubMed    
   
   
   
2. TIAN Q, Liu M, Zhong F, Liu X, et al
   Lecanemab treatment for mild alzheimer's disease with high risk of cerebral hemorrhage: a case report.
   BMC Neurol. 2026 Jan 9. doi: 10.1186/s12883-025-04581.
   PubMed     Abstract available
   
   
   December 2025
3. ZHANG HE, Xiao ML, Ji JJ, Cheng YR, et al
   Integrating machine learning and experiments to elucidate the potential molecular mechanisms of methylparaben-induced Alzheimer's disease: evidence from a Tau hyperphosphorylation cell model.
   BMC Neurol. 2025 Dec 18. doi: 10.1186/s12883-025-04582.
   PubMed     Abstract available
   
   
   
4. ZENG S, Liu H, Han S, Chen J, et al
   The metabolic crossroads: glycolysis in cancer and neurodegeneration.
   BMC Neurol. 2025;26:9.
   PubMed     Abstract available
   
   
   November 2025
5. WU M, Gao L, Su Q, Wang H, et al
   Global burden, spatiotemporal disparities, and sex-specific trends of early- and late-onset Alzheimer's disease and other dementias: a comparative analysis and projections to 2035.
   BMC Neurol. 2025 Nov 24. doi: 10.1186/s12883-025-04530.
   PubMed     Abstract available
   
   
   
6. BASTAN F, Saeedi-Moghaddam F, Rashidian M, Mirhosseini F, et al
   Human herpesvirus 6 (HHV-6) infection and risk of Alzheimer's disease: a systematic review and meta-analysis.
   BMC Neurol. 2025 Nov 22. doi: 10.1186/s12883-025-04500.
   PubMed     Abstract available
   
   
   September 2025
7. DONG X, Li Y, Hao J, Zhou P, et al
   Convolutional neural network models of structural MRI for discriminating categories of cognitive impairment: a systematic review and meta-analysis.
   BMC Neurol. 2025;25:400.
   PubMed     Abstract available
   
   
   
8. ISMAIL YA, Auf HA, Sadik SA, Ahmed NM, et al
   Sensitivity and specificity of the Montreal cognitive assessment using U.S. National alzheimer coordinating centre uniform data set: a retrospective analysis of 16,309 participants.
   BMC Neurol. 2025;25:381.
   PubMed     Abstract available
   
   
   August 2025
9. XU Y, Gao Y
   The global patent landscape of the drugs for treating Alzheimer's disease from 2014-2023.
   BMC Neurol. 2025;25:361.
   PubMed     Abstract available
   
   
   
10. EBRAHIMI R, Mohammad Soltani S, Masouri MM, Seifi M, et al
    Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis.
    BMC Neurol. 2025;25:344.
    PubMed     Abstract available
    
    
    
11. NOVINBAHADOR T, Abbasi A, Molani-Gol R, Aghebati-Maleki L, et al
    Neuroprotection through adiponectin receptor agonist: an updated meta-analysis of preclinical Alzheimer's disease studies.
    BMC Neurol. 2025;25:320.
    PubMed     Abstract available
    
    
    July 2025
12. ZHANG Y, Xu K, Wang Y, Shen Y, et al
    Efficacy of repetitive transcranial magnetic stimulation in cognitive impairment of neurodegenerative diseases: a systematic review and meta-analysis.
    BMC Neurol. 2025;25:295.
    PubMed     Abstract available
    
    
    
13. GHADERI S, Mohammadi S, Fatehi F, Sisakhti M, et al
    Validation of dementia-free status in the iranian brain imaging database using ADNI data: a transition point from middle age to older adulthood.
    BMC Neurol. 2025;25:286.
    PubMed     Abstract available
    
    
    
14. WANG Y, Yu Q, Chen B, Zhou J, et al
    Two cases of Amyloid-Related Imaging Abnormalities (ARIA) following lecanemab treatment for alzheimer's disease and a literature review.
    BMC Neurol. 2025;25:281.
    PubMed     Abstract available
    
    
    
15. LONG Y, Liu J, Guo J, Jiang J, et al
    Integrated genetic analysis of Alzheimer's disease and stroke subtypes: insights from LDSC, PLACO, and MR studies.
    BMC Neurol. 2025;25:260.
    PubMed     Abstract available
    
    
    June 2025
16. SHEIKHI K, Momenabadi V, Khosravi S, Souri A, et al
    Burden of risk factors attributable to Alzheimer's disease and other dementia and its relationship with the Socio-Demographic index in Asia.
    BMC Neurol. 2025;25:247.
    PubMed     Abstract available
    
    
    May 2025
17. MODIRI A, Hosseini L, Abolhasanpour N, Azizi H, et al
    Mitotherapy in Alzheimer's and Parkinson's diseases: A systematic review of preclinical studies.
    BMC Neurol. 2025;25:227.
    PubMed     Abstract available
    
    
    
18. XU R, Gao Y
    CD28(+) CD45RA(-) CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study.
    BMC Neurol. 2025;25:203.
    PubMed     Abstract available
    
    
    April 2025
19. WANG L, Ding Y, Tang Y, Yang M, et al
    Association between sphingomyelin levels and gut microbiota abundance in Alzheimer's disease: a two-sample Mendelian randomization study.
    BMC Neurol. 2025;25:191.
    PubMed     Abstract available
    
    
    
20. YANG Z, Liu L, You T, Wang L, et al
    Comparative study of brain functional imaging of brain in patients with mild to moderate Alzheimer's disease based on functional near infrared spectroscopy.
    BMC Neurol. 2025;25:186.
    PubMed     Abstract available
    
    
    
21. JIN T, Huang W, Cheng Y, Cao Z, et al
    Potential association between allergic disease and risk of Alzheimer's disease: insight from genetic analysis.
    BMC Neurol. 2025;25:173.
    PubMed     Abstract available
    
    
    
22. ZHANG B, Xu B, Zhang R, Gong B, et al
    Dysregulated interleukin networks drive immune heterogeneity in Alzheimer's disease: an immunogenomic approach to subgroup classification and predictive modeling.
    BMC Neurol. 2025;25:154.
    PubMed     Abstract available
    
    
    
23. NEMATI R, Sohrabi-Ashlaghi A, Saberian P, Sadeghi M, et al
    Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer's dementia continuum: an [(18) F] AV-45 study.
    BMC Neurol. 2025;25:134.
    PubMed     Abstract available
    
    
    February 2025
24. OOMENS JE, Moonen JEF, Vos SJB, Beran M, et al
    Identifying pathways to the prevention of dementia: the Netherlands consortium of dementia cohorts.
    BMC Neurol. 2025;25:59.
    PubMed     Abstract available
    
    
    
25. ISMAIL YA, Haitham Y, Walid M, Mohamed H, et al
    Efficacy of acetylcholinesterase inhibitors on reducing hippocampal atrophy rate: a systematic review and meta-analysis.
    BMC Neurol. 2025;25:60.
    PubMed     Abstract available
    
    
    
26. LINZHU, Zhang J, Fan W, Su C, et al
    Influence of immune cells and inflammatory factors on Alzheimer's disease axis: evidence from mediation Mendelian randomization study.
    BMC Neurol. 2025;25:49.
    PubMed     Abstract available
    
    
    December 2024
27. QIAO M, Wu H, Chi L, Yao Q, et al
    A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease: a case report.
    BMC Neurol. 2024;24:489.
    PubMed     Abstract available
    
    
    
28. SIRIPAOPRADIT Y, Chatsirisakul O, Ariyapaisalkul T, Sereemaspun A, et al
    Exploring the gut-brain axis in alzheimer's disease treatment via probiotics: evidence from animal studies-a systematic review and meta-analysis.
    BMC Neurol. 2024;24:481.
    PubMed     Abstract available
    
    
    
29. DEVULDER A, Vanderlinden G, Cleeren E, Goovaerts V, et al
    A case report about focal status epilepticus as first presentation in Alzheimer's disease: finding the culprit.
    BMC Neurol. 2024;24:478.
    PubMed     Abstract available
    
    
    November 2024
30. WANG W, Zhang J, Zhang M, Zhang C, et al
    Impact of diabetes mellitus on the risk of Alzheimer's disease: a mendelian randomization study.
    BMC Neurol. 2024;24:448.
    PubMed     Abstract available
    
    
    
31. ZAMAN Z, Islam R, Koganti B, Falki V, et al
    Highly prevalent geriatric medications and their effect on beta-amyloid fibril formation.
    BMC Neurol. 2024;24:445.
    PubMed     Abstract available
    
    
    October 2024
32. AKHGARJAND C, Hashemi R, Amini M, Rasekhi H, et al
    The relationship between micronutrients and cognitive ability in an elderly population with mild cognitive impairment and Alzheimer's disease: a cross-sectional study.
    BMC Neurol. 2024;24:416.
    PubMed     Abstract available
    
    
    
33. ARIAEI A, Ghorbani A, Habibzadeh E, Moghaddam N, et al
    Investigating the association between the GAP-43 concentration with diffusion tensor imaging indices in Alzheimer's dementia continuum.
    BMC Neurol. 2024;24:397.
    PubMed     Abstract available
    
    
    September 2024
34. RAJI CA, Meysami S, Porter VR, Merrill DA, et al
    Diagnostic utility of brain MRI volumetry in comparing traumatic brain injury, Alzheimer disease and behavioral variant frontotemporal dementia.
    BMC Neurol. 2024;24:337.
    PubMed     Abstract available
    
    
    July 2024
35. HU Q, Shi M, Li Y, Zhao X, et al
    Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.
    BMC Neurol. 2024;24:236.
    PubMed     Abstract available
    
    
    June 2024
36. ZHU W, Zhou X, Ren M, Yin W, et al
    Process approach as a cognitive biomarker related to gray matter volume in mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2024;24:199.
    PubMed     Abstract available
    
    
    April 2024
37. ALTY J, Goldberg LR, Roccati E, Lawler K, et al
    Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum.
    BMC Neurol. 2024;24:127.
    PubMed     Abstract available
    
    
    
38. LANE RM, Darreh-Shori T, Junge C, Li D, et al
    Onset of Alzheimer disease in apolipoprotein varepsilon4 carriers is earlier in butyrylcholinesterase K variant carriers.
    BMC Neurol. 2024;24:116.
    PubMed     Abstract available
    
    
    
39. SVENSSON JE, Bolin M, Thor D, Williams PA, et al
    Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol.
    BMC Neurol. 2024;24:111.
    PubMed     Abstract available
    
    
    March 2024
40. SHEN M, Zhang L, Chen C, Wei X, et al
    Investigating the causal relationship between immune cell and Alzheimer's disease: a mendelian randomization analysis.
    BMC Neurol. 2024;24:98.
    PubMed     Abstract available
    
    
    
41. KWAK S, Kim H, Kim KY, Oh DY, et al
    Neuroanatomical and neurocognitive correlates of delusion in Alzheimer's disease and mild cognitive impairment.
    BMC Neurol. 2024;24:89.
    PubMed     Abstract available
    
    
    February 2024
42. RAJENDRAKUMAR AL, Arbeev KG, Bagley O, Yashin AI, et al
    The SNP rs6859 in NECTIN2 gene is associated with underlying heterogeneous trajectories of cognitive changes in older adults.
    BMC Neurol. 2024;24:78.
    PubMed     Abstract available
    
    
    
43. YE S, Roccati E, Wang W, Zhu Z, et al
    Leading determinants of incident dementia among individuals with and without the apolipoprotein E epsilon4 genotype: a retrospective cohort study.
    BMC Neurol. 2024;24:71.
    PubMed     Abstract available
    
    
    January 2024
44. YANG X, Gan J, Ji Y
    Association between cerebrospinal fluid pressure and cognition in patients with Alzheimer's disease and Lewy body dementia.
    BMC Neurol. 2024;24:35.
    PubMed     Abstract available
    
    
    December 2023
45. ZHU XC, Tang BF, Zhu MZ, Lu J, et al
    Analysis of complement system and its related factors in Alzheimer's disease.
    BMC Neurol. 2023;23:446.
    PubMed     Abstract available
    
    
    November 2023
46. BUONGIORNO M, Granell E, Caruana G, Sansa G, et al
    Impairments in sleep and brain molecular clearance in people with cognitive deterioration and biological evidence of AD: a report of four cases.
    BMC Neurol. 2023;23:417.
    PubMed     Abstract available
    
    
    
47. DIBELLO JR, Lu Y, Swartz J, Bortnichak EA, et al
    Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD).
    BMC Neurol. 2023;23:400.
    PubMed     Abstract available
    
    
    October 2023
48. LI Z, Wu H, Luo Y, Tan X, et al
    Correction: Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer's disease of different severity.
    BMC Neurol. 2023;23:347.
    PubMed    
    
    
    September 2023
49. SAHRAI H, Norouzi A, Hamzehzadeh S, Majdi A, et al
    SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis.
    BMC Neurol. 2023;23:331.
    PubMed     Abstract available
    
    
    
50. LI Z, Wu H, Luo Y, Tan X, et al
    Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer's disease of different severity.
    BMC Neurol. 2023;23:319.
    PubMed     Abstract available
    
    
    August 2023
51. AHMADZADEH M, Christie GJ, Cosco TD, Arab A, et al
    Neuroimaging and machine learning for studying the pathways from mild cognitive impairment to alzheimer's disease: a systematic review.
    BMC Neurol. 2023;23:309.
    PubMed     Abstract available
    
    
    
52. CROWELL V, Reyes A, Zhou SQ, Vassilaki M, et al
    Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set.
    BMC Neurol. 2023;23:302.
    PubMed     Abstract available
    
    
    
53. MAZZEO S, Lassi M, Padiglioni S, Vergani AA, et al
    PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.
    BMC Neurol. 2023;23:300.
    PubMed     Abstract available
    
    
    
54. VAN DE SANDE N, Ramakers IHGB, Visser PJ, Verhey FRJ, et al
    Tear biomarkers for Alzheimer's disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study.
    BMC Neurol. 2023;23:293.
    PubMed     Abstract available
    
    
    May 2023
55. ZHANG J, Zheng X, Zhao Z
    A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease.
    BMC Neurol. 2023;23:210.
    PubMed     Abstract available
    
    
    
56. BROWN CW, Chen HY, Panegyres PK
    Electroencephalography in young onset dementia.
    BMC Neurol. 2023;23:202.
    PubMed     Abstract available
    
    
    April 2023
57. SISODIA V, Swinnen BEKS, Dijk JM, Verwijk E, et al
    Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE).
    BMC Neurol. 2023;23:160.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.